AIM IMMUNOTECH INC's ticker is AIM and the CUSIP is 00901B105. A total of 39 filers reported holding AIM IMMUNOTECH INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,036 | -32.1% | 2,276 | 0.0% | 0.00% | – |
| Q2 2023 | $1,525 | +55.8% | 2,276 | 0.0% | 0.00% | – |
| Q1 2023 | $979 | +1278.9% | 2,276 | 0.0% | 0.00% | – |
| Q4 2022 | $71 | -96.4% | 2,276 | -7.3% | 0.00% | – |
| Q3 2022 | $2,000 | 0.0% | 2,454 | -0.0% | 0.00% | – |
| Q2 2022 | $2,000 | +100.0% | 2,455 | +68.7% | 0.00% | – |
| Q1 2022 | $1,000 | -66.7% | 1,455 | -57.9% | 0.00% | – |
| Q4 2021 | $3,000 | 0.0% | 3,455 | +137.5% | 0.00% | – |
| Q3 2021 | $3,000 | +50.0% | 1,455 | +70.2% | 0.00% | – |
| Q2 2021 | $2,000 | +100.0% | 855 | +87.5% | 0.00% | – |
| Q1 2021 | $1,000 | 0.0% | 456 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | 0.0% | 456 | +0.2% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 455 | +0.2% | 0.00% | – |
| Q2 2020 | $1,000 | -98.4% | 454 | -98.1% | 0.00% | – |
| Q1 2020 | $61,000 | – | 23,772 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| XTX MARKETS LLC | 11,019 | $20,000 | 0.04% |
| Virtu Financial LLC | 103,807 | $186,000 | 0.02% |
| ACT WEALTH MANAGEMENT, LLC | 10,000 | $18,000 | 0.01% |
| SeaCrest Wealth Management, LLC | 48,873 | $87,000 | 0.01% |
| Arkadios Wealth Advisors | 20,000 | $35,000 | 0.01% |
| Traynor Capital Management, Inc. | 14,777 | $26,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 17,047 | $31,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 111,000 | $199,000 | 0.00% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 20,200 | $36,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 12,513 | $22,000 | 0.00% |